We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
RE MAX Holdings Inc | NYSE:RMAX | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 7.20 | 0 | 01:00:00 |
By Josh Beckerman
Shares of Re/Max Holdings, uniQure and Trinseo fell to 52-week lows Tuesday on news that the stocks will be removed from the S&P SmallCap 600.
Shares of real-estate brokerage franchiser Re/Max were recently down 12% to $14.51, with a low of $13.62 for the day. The 52-week high of $24.28 was set Feb. 2.
UniQure was down 12% to $7.69, with a low of $7.40 Tuesday. The gene therapy company's shares reached a 52-week high of $28.26 on Nov. 29. On Tuesday, the company said the U.S. Food and Drug Administration cleared its investigational new drug application for AMT-260, a gene therapy candidate for refractory mesial temporal lobe epilepsy.
Shares of Trinseo, whose products include plastics and latex binders, were recently down 19% to $8.73. The new 52-week low was $8.04. The 52-week high of $30.54 occurred Feb. 3.
S&P Dow Jones Indices announced a wide range of index changes that will take effect Sept. 18 to coincide with the quarterly rebalance. The changes are intended to make each index more representative of its market capitalization range.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
September 05, 2023 13:44 ET (17:44 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year RE MAX Chart |
1 Month RE MAX Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions